6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
AssigneePfizer Inc.
InventorWayne E. Barth
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorWayne E. Barth
Estimating the term…
Beta-lactamase inhibitors which are aminoacid esters of 6-alpha- and 6-beta-(hydroxymethyl)pencillanic acid 1,1-dioxides; pharmaceutically-acceptable salts thereof; conventional esters thereof which are hydrolyzable in vivo; bis-methanediol esters thereof; or mixed methanediol esters with said beta-lactamase inhibitors and sulbactam. Pharmaceutical compositions comprising said beta-lactamase inhibitors and a conventional beta-lactam antibiotic, said compositions useful in the treatment of bacterial infections. Compounds useful as intermediates in the synthesis of said beta-lactamase inhibitors. Antibacterial mixed bis-methanediol esters of said aminoacyloxymethyl penicillanic acid 1,1-dioxides and ampicillin or amoxicillin, also useful in the treatment of bacterial infections; and intermediates therefor.
A compound having the formula ##STR19## wherein R is ##STR20## R.sup.3, R.sup.4 and R.sup.5 are each independently hydrogen or (C.sub.1 -C.sub.3)alkyl;
A compound having the formula ##STR28## wherein R is ##STR29## R.sup.3, R.sup.4 and R.sup.5 are each independently hydrogen or (C.sub.1 -C.sub.3)alkyl;
Dependencies are inferred from the claim text.